drugset / Trial / NCT00909311

Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir

NCT00909311

Phase 1 Completed 8 enrolled Abbott
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of food on pharmacokinetics, safety and tolerability of an experimental Hepatitis C Virus (HCV) protease inhibitor with ritonavir in healthy volunteers.

Timeline

Start
2009-05
Primary completion
2009-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator paritaprevir Small molecule
Comparator Ritonavir Other / unclassified